Loading
Latest filing published 31 Jul 2026 for Cannara Biotech Inc., €60k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Olymbec Investments Inc. is known so far (31 July 2026): an open-market purchase, €60k, in Cannara Biotech Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration